282 related articles for article (PubMed ID: 12809097)
1. Glaxo drops drug prices, AIDS foundation drops suit.
AIDS Policy Law; 2003 May; 18(10):6. PubMed ID: 12809097
[No Abstract] [Full Text] [Related]
2. Embarrassed firms slash prices for AIDs drugs.
Boseley S
N Z Med J; 2001 Oct; 114(1141):440. PubMed ID: 11700768
[No Abstract] [Full Text] [Related]
3. Uganda cuts AIDS drug deal.
IAPAC Mon; 2001 Feb; 7(2):40. PubMed ID: 11302022
[No Abstract] [Full Text] [Related]
4. Companies reduce prices for HIV drugs in developing countries.
Gottlieb S
Bull World Health Organ; 2000; 78(6):862. PubMed ID: 10916926
[TBL] [Abstract][Full Text] [Related]
5. AIDS activists decry steady hikes in HIV drug prices.
AIDS Policy Law; 2005 Jul; 20(14):1, 4. PubMed ID: 16110523
[No Abstract] [Full Text] [Related]
6. Policy watch. Profitable pills.
Gebbie KM
AIDS Read; 2004 Mar; 14(3):106, 109. PubMed ID: 15067998
[No Abstract] [Full Text] [Related]
7. Drug makers to cut prices for developing countries.
AIDS Alert; 1998 Aug; 13(8 Suppl):1-2. PubMed ID: 11365655
[TBL] [Abstract][Full Text] [Related]
8. [GlaxoSmithKline again lowers prices of drugs for HIV/AIDS and malaria].
Krankenpfl J; 2002; 40(7-9):222-3. PubMed ID: 12514863
[No Abstract] [Full Text] [Related]
9. AIDS research. Drug trials without the drugs?
Cohen J
Science; 2003 May; 300(5623):1212-3. PubMed ID: 12764159
[No Abstract] [Full Text] [Related]
10. Treatment. HIV drug spending up; Merck offers discounts.
AIDS Policy Law; 2010 Jun; 25(7):1. PubMed ID: 20607912
[No Abstract] [Full Text] [Related]
11. [Glaxo Wellcome, Germany, spends 60.000 DM for African HIV projects in Uganda and Malawi].
Krankenpfl J; 1999 Dec; 37(12):479. PubMed ID: 10734858
[No Abstract] [Full Text] [Related]
12. Merck, Bristol-Myers Squibb announce major price reductions for poorest countries: major access progress but questions remain.
James JS
AIDS Treat News; 2001 Feb; (361):5-7. PubMed ID: 12765151
[TBL] [Abstract][Full Text] [Related]
13. World Trade Organization still threatens supply of affordable AIDS drugs.
Hagmann M
Bull World Health Organ; 2002; 80(9):762-3. PubMed ID: 12378300
[No Abstract] [Full Text] [Related]
14. Glaxo Wellcome expands Patient Assistance Program for 3TC.
AIDS Patient Care STDS; 1996 Aug; 10(4):262. PubMed ID: 11361605
[No Abstract] [Full Text] [Related]
15. Drug prices.
AIDS Policy Law; 1996 Dec; 11(22):12. PubMed ID: 11364060
[TBL] [Abstract][Full Text] [Related]
16. The looming crisis in drug pricing.
Delaney M
GMHC Treat Issues; 2002 Apr; 16(4):12. PubMed ID: 12141258
[No Abstract] [Full Text] [Related]
17. [HIV therapy: tenofir DF is available in 68 developing countries at production costs price].
Med Klin (Munich); 2003 Jul; 98(7):XV-XVI. PubMed ID: 12945544
[No Abstract] [Full Text] [Related]
18. GlaxoSmithKline, under pressure, cuts price of AIDS treatment for poor countries.
Fleck F
Bull World Health Organ; 2003; 81(6):469. PubMed ID: 12894339
[No Abstract] [Full Text] [Related]
19. Essential AIDS medications in India.
Thomas J
Issues Med Ethics; 2000; 8(2):62. PubMed ID: 16323350
[No Abstract] [Full Text] [Related]
20. Balancing pills and patents: intellectual property and the HIV/AIDS crisis.
Nderitu T
E Law; 2001 Sep; 8(3):E5. PubMed ID: 16903022
[No Abstract] [Full Text] [Related]
[Next] [New Search]
